English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#drlalpathlabs search results

ETNowSwadesh's profile picture. A Times Network Company YouTube: https://t.co/H3uxIZjQOl Facebook: https://t.co/FLEQy2T1wv Instagram: https://t.co/xn3a6UJpyo
ET Now Swadesh
@ETNowSwadesh
Nov 3

नतीजों पर डॉ. लाल पैथलैब्स के मैनेजमेंट से बातचीत - कैसे रहे Q2 के नतीजे? - आगे के लिए क्या है ग्रोथ आउटलुक? देखिए @lalpathlabs के CEO, शंख बनर्जी से खास बातचीत #StockMarket #DrLalPathLabs @NewzzPandey

0
0
0
0
251
ashesh242's profile picture. Ex servicemen I investor I Passionate about investing | Personal Help To All Fauzi Bhai
asheshbajpai
 @ashesh242
Nov 1

#DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable

ashesh242's tweet image. #DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable
1
2
4
0
144
ETNOWlive's profile picture. Your ultimate destination for business news, economic insights and expert opinions. Rise with India! Rise with ET NOW!
ET NOW
@ETNOWlive
Sep 24

#StockInNews | Dr. Lal PathLabs board approves acquisition of property in New Delhi worth ₹74.51 crore @DrlalpathL70581 #DrLalPathLabs #CorporateUpdate #BoardApproval

ETNOWlive's tweet image. #StockInNews | Dr. Lal PathLabs board approves acquisition of property in New Delhi worth ₹74.51 crore @DrlalpathL70581 #DrLalPathLabs #CorporateUpdate #BoardApproval
1
1
0
1
2K
MoneycontrolH's profile picture. Moneycontrol न्यूज़ अब हिंदी में
Moneycontrol Hindi
 @MoneycontrolH
Oct 31

#MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…

MoneycontrolH's tweet image. #MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…
0
0
1
0
136
ZeeBusiness's profile picture. ZEE BUSINESS is India’s Number 1 Hindi business news channel. It's your channel for profit and wealth. Download App - https://t.co/yoRVtU2WPI
Zee Business
@ZeeBusiness
Oct 31

💉 #DrLalPathLabs #Q2FY26 Update! The healthcare major reports a 10.7% YoY revenue rise to ₹731 crore and delights shareholders with a second interim dividend + bonus issue #HealthcareStocks zeebiz.com/market-news/ne…

ZeeBusiness's tweet card. Healthcare service provider, Dr Lal PathLabs Limited, announced its financial results for the quarter ended September 30, 2025, along with a major reward for shareholders, a second interim dividend...
Rs 7 Dividend + 1:1 Bonus Issue: BSE smallcap firm declares double delight in Q2 result - Record...
Source: zeebiz.com
0
0
5
0
2K
pradeepsardana's profile picture. Sr.Journalist, Film Critic, TV Panelist with National News Channels, Founder Editor-PUNARVAS Online, Poet, Youngest Editor in India, Pioneer in Journalism on TV
Pradeep Sardana
@pradeepsardana
Oct 19, 2023

Extremely disappointed with the unprofessional services & untrained phlebotomist of @lalpathlabs . Claims of the brand of trust & quality are completely false. Wrong prices, unskilled way of taking samples, roaming whole day with the samples. Terrible experience #DrLalPathLabs

pradeepsardana's tweet image. Extremely disappointed with the unprofessional services & untrained phlebotomist of @lalpathlabs . Claims of the brand of trust & quality are completely false. Wrong prices, unskilled way of taking samples, roaming whole day with the samples. Terrible experience #DrLalPathLabs
1
3
4
0
126
TCymatics's profile picture. Renko Based Options | Market Simplifier | Trend Trader | System Builder | 16 years of Options Trading | Trading Zones !!
Trade Cymatics
@TCymatics
Sep 21

DR.LALPATH LABS #DRLALPATHLABS DAILY #BREAKOUTSTOCKS CMP: 3473 BREAKING OUT to DEMAND zone on DAILIES 🥳 Telegram: t.me/TradeCymatics #StocksInFocus #StockMarket #stocks #Nifty #GIFTNIFTY #stockmarkets

TCymatics's tweet image. DR.LALPATH LABS #DRLALPATHLABS DAILY #BREAKOUTSTOCKS CMP: 3473 BREAKING OUT to DEMAND zone on DAILIES 🥳 Telegram: t.me/TradeCymatics #StocksInFocus #StockMarket #stocks #Nifty #GIFTNIFTY #stockmarkets
0
0
6
1
520
karansarin4's profile picture. Stock market full time trader. F&O & Discretionary Trader! Follow my telegram page for educational purpose,intraday and swing trade moves!
Karan Sarin
 @karansarin4
Jan 7

Discussed Dr Lal path labs yesterday in space and live market as well. Gave a beautiful follow through and closing today. Grateful Let's learn and earn together! @wealth_verse @AnubhavTalwar @PotemkinThinker #NSE #drlalpathlabs #diagnostics #HPMV#StocksToBuy #intradaytrading

karansarin4's tweet image. Discussed Dr Lal path labs yesterday in space and live market as well. Gave a beautiful follow through and closing today. Grateful Let's learn and earn together! @wealth_verse @AnubhavTalwar @PotemkinThinker #NSE #drlalpathlabs #diagnostics #HPMV#StocksToBuy #intradaytrading
0
2
4
0
694
EveryStockData's profile picture. I'm working 24x7 to update more than 5000 companies stock data every day to improve investment in India. Please Donate.
Every Stock Data of India 🇮🇳
@EveryStockData
Nov 9, 2023

#DrLalPathLabs Results Sep 2023 (Standalone_YoY) revenue elevated to 532 crs up 13% in Sep 2023 qtr, compared with 467 crs in Sep 2022. Its Net profit is 113 crs up 43% in Sep 2023 qtr, compared with 79 crs in last year same qtr. Only Data. Not Buy or Sell advice.

EveryStockData's tweet image. #DrLalPathLabs Results Sep 2023 (Standalone_YoY) revenue elevated to 532 crs up 13% in Sep 2023 qtr, compared with 467 crs in Sep 2022. Its Net profit is 113 crs up 43% in Sep 2023 qtr, compared with 79 crs in last year same qtr. Only Data. Not Buy or Sell advice.
EveryStockData's tweet image. #DrLalPathLabs Results Sep 2023 (Standalone_YoY) revenue elevated to 532 crs up 13% in Sep 2023 qtr, compared with 467 crs in Sep 2022. Its Net profit is 113 crs up 43% in Sep 2023 qtr, compared with 79 crs in last year same qtr. Only Data. Not Buy or Sell advice.
0
0
0
0
86
ETNOWlive's profile picture. Your ultimate destination for business news, economic insights and expert opinions. Rise with India! Rise with ET NOW!
ET NOW
@ETNOWlive
Aug 23, 2024

Take a quick look at the management meet takeaways- Dr Lal Path Labs👇 #DrLalPathLabs

ETNOWlive's tweet image. Take a quick look at the management meet takeaways- Dr Lal Path Labs👇 #DrLalPathLabs
0
1
10
1
3K
CNBCTV18Live's profile picture. The CNBC-TV18 news ticker on Twitter. The news breaks here first. WhatsApp: https://t.co/7R212M3KJN
CNBC-TV18
 @CNBCTV18Live
Jun 23

#CNBCTV18Market | Diagnostics stocks lower after #Amazon launches home diagnostic services in 6 cities through app. #DrLalPathLabs & #MetropolisHealth down over 2%

CNBCTV18Live's tweet image. #CNBCTV18Market | Diagnostics stocks lower after #Amazon launches home diagnostic services in 6 cities through app. #DrLalPathLabs & #MetropolisHealth down over 2%
2
17
112
4
15K
CNBCTV18Live's profile picture. The CNBC-TV18 news ticker on Twitter. The news breaks here first. WhatsApp: https://t.co/7R212M3KJN
CNBC-TV18
 @CNBCTV18Live
Apr 25

#4QWithCNBCTV18 | #DrLalPathLabs to announce their Q4 earnings today Expect revenue growth at 10% & margin to see a 20bps contraction

CNBCTV18Live's tweet image. #4QWithCNBCTV18 | #DrLalPathLabs to announce their Q4 earnings today Expect revenue growth at 10% & margin to see a 20bps contraction
3
0
25
0
7K
marketgreeks's profile picture. Option trader #NSE #Nifty Education purpose only Telegram : https://t.co/M6fW0pVfEl Instagram : https://t.co/dGc0lQQ5nN
marketgreeks
 @marketgreeks
Nov 7

#DrLalPathLabs Limited Considered to Issuing Bonus Equity Shares #Nifty #StockMarket #sharemarket #Sensex

0
0
0
0
72
ETNowSwadesh's profile picture. A Times Network Company YouTube: https://t.co/H3uxIZjQOl Facebook: https://t.co/FLEQy2T1wv Instagram: https://t.co/xn3a6UJpyo
ET Now Swadesh
@ETNowSwadesh
Nov 3

नतीजों पर डॉ. लाल पैथलैब्स के मैनेजमेंट से बातचीत - कैसे रहे Q2 के नतीजे? - आगे के लिए क्या है ग्रोथ आउटलुक? देखिए @lalpathlabs के CEO, शंख बनर्जी से खास बातचीत #StockMarket #DrLalPathLabs @NewzzPandey

0
0
0
0
251
Navoneetbhatt3's profile picture. Hello 🙋‍♂️ Everyone 🍁 My Name is Navoneet Bhattacharjee. I'm a Bcom Hons Graduate 🎓 And I'm a Private Tutior. For Tution Contact Mobile - 9864668614.
Navoneet Bhattacharjee
 @Navoneetbhatt3
Nov 2

Dr Lal Pathlabs Ltd Bonus Issue 1:1 Ratio + Interim Dividend Announced Rs.6/- per share For FY26 | NTPC Ltd Share Interim Dividend Rs.2.75/- per share For FY26 | Shriram Finance Ltd Interim Dividend Rs.4.80/- per share For FY26 | #drlalpathlabs #ntpc #ntpcdividend #navoneetbhatt

Navoneetbhatt3's tweet image. Dr Lal Pathlabs Ltd Bonus Issue 1:1 Ratio + Interim Dividend Announced Rs.6/- per share For FY26 | NTPC Ltd Share Interim Dividend Rs.2.75/- per share For FY26 | Shriram Finance Ltd Interim Dividend Rs.4.80/- per share For FY26 | #drlalpathlabs #ntpc #ntpcdividend #navoneetbhatt
0
0
1
0
191
ashesh242's profile picture. Ex servicemen I investor I Passionate about investing | Personal Help To All Fauzi Bhai
asheshbajpai
 @ashesh242
Nov 1

#DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable

ashesh242's tweet image. #DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable
1
2
4
0
144
Prefmarkits's profile picture.
Prefurred Markits
 @Prefmarkits
Nov 1

Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs

Prefmarkits's tweet image. Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs
Prefmarkits's tweet image. Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs
0
0
0
0
48
marketsday's profile picture. Global Stock markets related news, Companies Earnings, Global Economy Business, Economic events, Commodity, Political and War real-time news updates.
Markets Today
 @marketsday
Nov 1

Dr Lal PathLabs reports a 16.4% Y-o-Y increase in consolidated net profit for Q2 FY26 at ₹152 crore, up from ₹131 crore reported for the same period last year. #DrLalPathLabs #Q2FY26 #Q2Results #Q2FY26Results

0
0
1
0
180
bsindia's profile picture. Latest news on the economy, companies, markets, politics and technology from India's leading business daily. WhatsApp link: https://t.co/dOfKBRwpY0
Business Standard
@bsindia
Nov 1

Dr Lal PathLabs reports a 16.4% Y-o-Y increase in consolidated net profit for Q2 FY26 at ₹152 crore, up from ₹131 crore reported for the same period last year. @koul_sanket reports #DrLalPathLabs #Q2FY26 #Q2Results #Q2FY26Results mybs.in/2er11QE

bsindia's tweet card. Diagnostics chain declares ₹7 per share interim dividend, 1:1 bonus issue
Dr Lal PathLabs Q2 results: PAT up 16.4% at ₹152 crore, revenue rises 11%
Source: business-standard.com
0
0
1
0
1K
oshorajani's profile picture. Journalist, YouTuber, Content Creator. EX-CNBC Awaaz, Zee Business, ETV News, Mahua News, TV9 Maharashtra, TV Asia USA.. Tweets=Personal & RTs not Endorsement
RAJANISH KANT@beyourmoneymanager
 @oshorajani
Nov 1

Dr Lal PathLabs: 1 शेयर पर ₹7.00 अंतरिम डिविडेंड, डिविडेंड का रिकॉर्ड डेट 7 नवंबर                #DrLalPathLabs #dividend #beyourmoneymanager #news #बीयोरमनीमैनेजर #stockmarket

0
0
0
0
21
oshorajani's profile picture. Journalist, YouTuber, Content Creator. EX-CNBC Awaaz, Zee Business, ETV News, Mahua News, TV9 Maharashtra, TV Asia USA.. Tweets=Personal & RTs not Endorsement
RAJANISH KANT@beyourmoneymanager
 @oshorajani
Nov 1

Dr Lal PathLabs: 1 शेयर पर 1 बोनस शेयर देगी यानी 1 शेयर फ्री देगी, बोनस शेयर के रिकॉर्ड डेट की घोषणा        #DrLalPathLabs #,BonusShare #beyourmoneymanager #news #stockmarket #बीयोरमनीमैनेजर

0
0
0
0
20
VikasSo75032776's profile picture. Investor / Swing trader https://t.co/wLKuPEwRiP
TheSupremeTrader004
@VikasSo75032776
Oct 31

#DrLalPathLabs #Q2Results 👍Net profit up 17% at ₹151 cr vs ₹129 cr (YoY) 👍Revenue up 11% at ₹731 cr vs ₹660 cr (YoY) 👍EBITDA up 11% at ₹224.3 cr vs ₹202 cr (YoY) ✔️ Margin flat at 31% (YoY) #Q2 #Q2FY26

0
0
0
0
26
ZeeBusiness's profile picture. ZEE BUSINESS is India’s Number 1 Hindi business news channel. It's your channel for profit and wealth. Download App - https://t.co/yoRVtU2WPI
Zee Business
@ZeeBusiness
Oct 31

💉 #DrLalPathLabs #Q2FY26 Update! The healthcare major reports a 10.7% YoY revenue rise to ₹731 crore and delights shareholders with a second interim dividend + bonus issue #HealthcareStocks zeebiz.com/market-news/ne…

ZeeBusiness's tweet card. Healthcare service provider, Dr Lal PathLabs Limited, announced its financial results for the quarter ended September 30, 2025, along with a major reward for shareholders, a second interim dividend...
Rs 7 Dividend + 1:1 Bonus Issue: BSE smallcap firm declares double delight in Q2 result - Record...
Source: zeebiz.com
0
0
5
0
2K
MoneycontrolH's profile picture. Moneycontrol न्यूज़ अब हिंदी में
Moneycontrol Hindi
 @MoneycontrolH
Oct 31

#MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…

MoneycontrolH's tweet image. #MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…
0
0
1
0
136
sourabhwadhwa22's profile picture. Engineer | Geo-politics Junkie | Stock Market Investor | Cricket fanatic. Exploring the world from code to commodities.📊🌍🏏
Mr. Wadhwa
@sourabhwadhwa22
Oct 31

🚨 Breaking News: Dr. Lal PathLabs Ltd approves Bonus Issue in 1:1 ratio 🧬 ➡️ Shareholders will receive 1 bonus share for every 1 share held. ➡️ Subject to shareholder approval and record date to be announced soon. #DrLalPathLabs #BonusIssue #StockMarket #CorporateAction…

0
3
3
0
92
Navoneetbhatt3's profile picture. Hello 🙋‍♂️ Everyone 🍁 My Name is Navoneet Bhattacharjee. I'm a Bcom Hons Graduate 🎓 And I'm a Private Tutior. For Tution Contact Mobile - 9864668614.
Navoneet Bhattacharjee
 @Navoneetbhatt3
Nov 2

Dr Lal Pathlabs Ltd Bonus Issue 1:1 Ratio + Interim Dividend Announced Rs.6/- per share For FY26 | NTPC Ltd Share Interim Dividend Rs.2.75/- per share For FY26 | Shriram Finance Ltd Interim Dividend Rs.4.80/- per share For FY26 | #drlalpathlabs #ntpc #ntpcdividend #navoneetbhatt

Navoneetbhatt3's tweet image. Dr Lal Pathlabs Ltd Bonus Issue 1:1 Ratio + Interim Dividend Announced Rs.6/- per share For FY26 | NTPC Ltd Share Interim Dividend Rs.2.75/- per share For FY26 | Shriram Finance Ltd Interim Dividend Rs.4.80/- per share For FY26 | #drlalpathlabs #ntpc #ntpcdividend #navoneetbhatt
0
0
1
0
191
MoneycontrolH's profile picture. Moneycontrol न्यूज़ अब हिंदी में
Moneycontrol Hindi
 @MoneycontrolH
Oct 31

#MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…

MoneycontrolH's tweet image. #MarketsWithMC: हेल्केयर सर्विस देने वाली Dr. Lal Path Labs ने शेयरहोल्डर्स के लिए डिविडेंड और बोनस शेयरों की घोषणा की है। कंपनी का सितंबर 2025 तिमाही में मुनाफा सालाना आधार पर 16 प्र​तिशत बढ़ गया। पढ़ें डिटेल... पूरी खबर👇 hindi.moneycontrol.com/news/photos/ma… #Q2Results #DrLalPathLabs…
0
0
1
0
136
Prefmarkits's profile picture.
Prefurred Markits
 @Prefmarkits
Nov 1

Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs

Prefmarkits's tweet image. Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs
Prefmarkits's tweet image. Dr Lal Path labs : Standalone & Consolidated (₹ in Mlns )-Sep’25 Overall : Excellent👍 Q2 : Sep25 vs June25 REV✅ PBT✅ PAT✅ EPS✅ LYQ : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ HY : Sep25 vs Sep24 REV✅ PBT✅ PAT✅ EPS✅ #finresults #drlalpathlabs
0
0
0
0
48
ashesh242's profile picture. Ex servicemen I investor I Passionate about investing | Personal Help To All Fauzi Bhai
asheshbajpai
 @ashesh242
Nov 1

#DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable

ashesh242's tweet image. #DRLALPATHLABS Q2 #Results #Nifty #NIFTYSMALLCAP100 @ProfitableW242 💰 Net Profit: ₹152 Cr 🆚 ₹130 Cr YoY ⬆️ 17% 📦 Revenue: ₹730 Cr 🆚 ₹660 Cr YoY ⬆️ 11% ⚙️ EBITDA: ₹224 Cr 🆚 ₹202 Cr YoY ⬆️ 11% 📊 EBITDA Margin: 30.67% 🆚 30.67% ➖ Stable
1
2
4
0
144
JindCc's profile picture.
Dr Lal Pathlabs Jind
 @JindCc
Nov 4

📍 Opposite Medical College, Haibatpur Road, Jind 📞 8818008384 💻 Book your test easily online or visit us today! 👉 Regular Health Checkups = Early Detection = Better Health #HealthAwareness #DrLalPathlabs #Jind #Diagnostics #Healthcare #HealthCheckup #Pathology #Wellness

JindCc's tweet image. 📍 Opposite Medical College, Haibatpur Road, Jind 📞 8818008384 💻 Book your test easily online or visit us today! 👉 Regular Health Checkups = Early Detection = Better Health #HealthAwareness #DrLalPathlabs #Jind #Diagnostics #Healthcare #HealthCheckup #Pathology #Wellness
0
0
0
0
0

Something went wrong.


Something went wrong.


United States Trends